Resultados de la búsqueda 51-60 de 3864 para treatment resistant depression
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
Copay assistance programs are offered by drug manufacturing companies as a direct way to lower out-of-pocket costs for drug costs for eligible patients. Copay ...
... treatment such as immunotherapy, target therapy and chemotherapy in lung cancer and mechanisms of resistance. The information generated from this study will ...
The purpose of this study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant ...
The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC).
The purpose of this study is to assess the safety and tolerability of ONO-7475 monotherapy in patients with relapsed or refractory acute myeloid leukemia or ...
... resistant chronic lymphocytic leukemia. Patients ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... Dabrafenib Combined With Trametinib ...
... treated with various forms of radiation therapy to improve the treatment of future patients. ... resistant or refractory ovarian cancer. A Study of Daunorubicin ...
... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...
... resistant chronic lymphocytic leukemia. Patients ... Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?